Knoll Capital Management, LLC - AMPIO PHARMACEUTICALS INC ownership

AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 76 filers reported holding AMPIO PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.36 and the average weighting 0.0%.

Quarter-by-quarter ownership
Knoll Capital Management, LLC ownership history of AMPIO PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2018$5,710,000
-35.3%
2,595,4840.0%4.85%
-46.5%
Q1 2018$8,825,000
-16.5%
2,595,4840.0%9.06%
-2.7%
Q4 2017$10,564,000
+556.6%
2,595,4840.0%9.31%
+576.8%
Q3 2017$1,609,000
+19.2%
2,595,4840.0%1.38%
-23.1%
Q2 2017$1,350,000
-38.4%
2,595,484
-5.2%
1.79%
-45.8%
Q1 2017$2,191,000
-12.1%
2,738,3220.0%3.30%
-24.5%
Q4 2016$2,492,000
+19.8%
2,738,3220.0%4.37%
+19.8%
Q3 2016$2,081,000
-50.2%
2,738,322
-15.4%
3.65%
+169.5%
Q2 2016$4,177,000
-45.2%
3,238,322
-4.4%
1.35%
-56.3%
Q1 2016$7,624,000
-35.7%
3,388,3220.0%3.10%
-29.6%
Q4 2015$11,859,000
+21.1%
3,388,3220.0%4.40%
+5.8%
Q3 2015$9,792,000
+20.9%
3,388,3220.0%4.16%
+59.2%
Q2 2015$8,098,000
-68.3%
3,388,3220.0%2.61%
-64.9%
Q1 2015$25,514,000
+119.5%
3,388,3220.0%7.43%
+62.5%
Q4 2014$11,622,000
-3.2%
3,388,322
+0.5%
4.57%
-2.0%
Q3 2014$12,000,000
-51.5%
3,370,822
+13.7%
4.67%
-57.7%
Q2 2014$24,753,000
+31.5%
2,964,4010.0%11.03%
+13.2%
Q1 2014$18,824,000
+30.3%
2,964,401
+46.2%
9.74%
+33.9%
Q4 2013$14,452,000
-4.9%
2,026,9980.0%7.28%
-10.3%
Q3 2013$15,202,000
+101.4%
2,026,998
+54.9%
8.11%
+57.1%
Q2 2013$7,550,0001,308,4555.16%
Other shareholders
AMPIO PHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Empery Asset Management, LP 4,262,409$2,430,0005.07%
CVI Holdings, LLC 5,171,896$2,948,0000.20%
PRIVATE CAPITAL MANAGEMENT LLC 937,237$534,0000.18%
CVA Family Office, LLC 1,137,920$649,0000.16%
ACT CAPITAL MANAGEMENT, LLC 291,500$166,0000.12%
Cypress Capital Management LLC (WY) 196,775$112,0000.09%
Willis Investment Counsel 2,181,840$1,244,0000.06%
NTB Financial Corp 146,100$83,0000.06%
Helen Stephens Group, LLC 117,222$67,0000.05%
SRS Capital Advisors, Inc. 629,172$359,0000.05%
View complete list of AMPIO PHARMACEUTICALS INC shareholders